Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies (opens in new window) for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Manage cookies
Accept & continue
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
myFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
    Most Read
    • How Trump’s vaccine effort produced results at ‘warp speed’
    • England hit with tough new regional Covid curbs
    • Merkel calls for closure of ski resorts across EU
    • Donald Trump says he will leave office if Joe Biden’s victory is confirmed
    • Hungary and Poland harden stance in EU budget stand-off
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    • US Presidential Election 2020
    Most Read
    • Delta and Alitalia to launch ‘quarantine free’ flights from US to Italy
    • How Trump’s vaccine effort produced results at ‘warp speed’
    • Salesforce talks to buy Slack foreshadow showdown with Microsoft
    • Donald Trump says he will leave office if Joe Biden’s victory is confirmed
    • Google ordered to hand over emails in £453m divorce battle
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Doubts raised over AstraZeneca-Oxford vaccine data
    • Delta and Alitalia to launch ‘quarantine free’ flights from US to Italy
    • German watchdog reports EY to prosecutors over Wirecard audit
    • Google ordered to hand over emails in £453m divorce battle
    • A hitchhiker’s guide to the City
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • What Mrs Watanabe can tell us about how to handle low returns
    • Indonesia woos US private equity for new sovereign wealth fund
    • Further reading
    • Goldman leads Wall Street bulls as markets ride high
    • Vaccine hopes set off rush for emerging markets
  • Climate
  • Graphics
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Work & Careers
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Bitcoin goes splat
    • Diego Maradona, Argentine football great, 1960-2020
    • Nostalgia is no substitute for a post-Brexit foreign policy
    • Saudi crown prince and Israel’s Netanyahu meet after Biden win
    • A hitchhiker’s guide to the City
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • McDonald’s Chris Kempczinski: ‘Our menu is very Darwinian’
    • Diego Maradona: too grand to pity
    • Best Books of the Year 2020
    • Life as commodity: Britain’s history of slavery
    • Treasury enjoys boost in capital gains tax receipts
  • How to Spend It
  • Sign In
  • Subscribe
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Graphics
  • Opinion
  • Life & Arts
  • How to Spend It
Financial Times
  • Sign In
  • Subscribe

David Crow

US Coronavirus Correspondent
David Crow is the FT's US coronavirus correspondent in New York. His previous roles include banking editor and senior US business correspondent. He also worked on the main news desk in London. Before joining the FT in 2012, he was managing editor of City AM.
Email David Crow @bydavidcrow (link opens in a new browser window)
Email David Crow @bydavidcrow (link opens in a new browser window)

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Friday, 23 October, 2020
    US presidential election 2020
    Presidential debate: How our columnists rated the last Trump-Biden battle — as it happened
  • Friday, 9 October, 2020
    AnalysisRegeneron Pharmaceuticals Inc
    Regeneron: the company that Trump claims cured his Covid

    President’s championing of novel therapy thrusts biotech group into uncomfortable spotlight

  • Thursday, 8 October, 2020
    US presidential election 2020
    Vice-presidential debate: read our columnists’ analysis of Harris, Pence and the fly — as it happened
  • Wednesday, 30 September, 2020
    US presidential election 2020
    Presidential debate: our experts’ insights from the Trump-Biden duel — as it happened
  • Thursday, 27 August, 2020
    FT Magazine
    Is this the end for America’s mom-and-pop stores?

    For small family businesses already struggling against retail chains and online giants, Covid-19 threatens to be a fatal blow

  • Monday, 24 August, 2020
    Coronavirus pandemic
    Trump considers fast-tracking UK Covid-19 vaccine before US election

    Move comes as FDA gives emergency authorisation for use of plasma from recovered patients

  • Monday, 24 August, 2020
    FT News Briefing podcast10 min listen
    Trump considers vaccine fast-track, dividends fall, Marble Ridge

    Trump considers fast tracking a UK coronavirus vaccine ahead of the presidential election

  • Thursday, 20 August, 2020
    Coronavirus: free to read
    Why is the ‘anti-vaxxer’ movement growing during a pandemic?

    US concerns that Trump will rush to approve a vaccine before election is playing into wider safety fears

  • Thursday, 6 August, 2020
    Coronavirus pandemic
    The next virus pandemic is not far away

    Scientists say new diseases will jump from animals unless humans change the way they live

  • Promoted Content
  • Wednesday, 5 August, 2020
    Coronavirus treatment
    J&J strikes $1bn Covid-19 vaccine deal with US

    Moderna to sell some doses of its own coronavirus jab candidate for between $32 and $37

  • Wednesday, 22 July, 2020
    ExplainerCoronavirus pandemic
    Test, test, test — but what can America do about the delays?

    Patients in the US are waiting more than a week for results, by which time it’s probably too late

  • Tuesday, 21 July, 2020
    Coronavirus: free to read
    US lab giant warns of new Covid-19 testing crunch in autumn

    Quest Diagnostics executive says ‘no way’ capacity will expand enough to cope with flu season

  • Sunday, 19 July, 2020
    Coronavirus pandemic
    Trump under pressure on test funding as Covid-19 surges

    President says mass testing ‘skews the numbers’ as governors say more money is needed

  • Friday, 17 July, 2020
    AnalysisThe Big Read
    US coronavirus surge: ‘It’s a failure of national leadership’

    Sunbelt states suffer a big rise in cases and deaths amid the growing politicisation of issues such as wearing masks

  • Thursday, 16 July, 2020
    Coronavirus treatment
    Lie on your front: the small things in Covid-19 survival

    Doctors in sunbelt states share lessons learnt from New York in hope of limiting deaths

  • Thursday, 2 July, 2020
    Coronavirus pandemic
    Independence Day: a star-spangled superspreader event

    US public health experts warn of heightened risk of virus transmission during July 4 celebrations

  • Tuesday, 30 June, 2020
    Coronavirus pandemic
    US hospitals buckle under surge of new coronavirus cases

    Intensive care units in parts of Texas and Arizona are operating near full capacity

  • Tuesday, 30 June, 2020
    Coronavirus treatment
    The hedge fund manager behind a long-shot coronavirus pill

    Wayne Holman and his wife Wendy are betting they can change the course of the pandemic

  • Thursday, 25 June, 2020
    Coronavirus pandemic
    Texas puts reopening on hold in face of new outbreak

    State leads nation in new coronavirus cases as US tallies another one-day record increase

  • Tuesday, 23 June, 2020
    Coronavirus pandemic
    Fauci calls for more virus testing to counter ‘disturbing surge’

    US posts largest one-day increase in cases in almost two months, led by Texas and California

  • Tuesday, 23 June, 2020
    Coronavirus pandemic
    Kudlow dismisses ‘second wave’ fears as US cases jump

    White House economic official’s comments come as Texas governor notes ‘unacceptable rate’ virus is spreading

  • Monday, 22 June, 2020
    AnalysisCenters for Disease Control and Prevention
    US disease-fighting agency struggles as it seeks to avoid Trump’s ire

    ‘Tragic downgrading’ of storied CDC during coronavirus pandemic harms its reputation

  • Friday, 19 June, 2020
    Coronavirus treatment
    US biotech group to trial Covid-19 pill for use at home

    Ridgeback will test twice-daily tablet to treat mild cases as well as those seriously ill in hospital

  • Sunday, 14 June, 2020
    ExplainerDisease control and prevention
    Pop-up testing: how New Orleans bent the coronavirus curve 

    City had been on course for one of worst outbreaks in the US before focus on deprived communities

  • Tuesday, 9 June, 2020
    Coronavirus: free to read
    Why coronavirus has fuelled black America’s sense of injustice

    African-Americans have been especially vulnerable during the pandemic, laying bare disparities in health and employment

Previous You are on page 1 Next

Useful links

Support

View Site TipsHelp CentreAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

FT LiveShare News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingContracts & Tenders
Executive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School Rankings
Enterprise ToolsNews feedNewslettersCurrency Converter
More from the FT Group
Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2020. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
    • US Presidential Election 2020
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Graphics
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Work & Careers
    • Lex
    • Obituaries
    • Letters
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • How to Spend It
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In